Literature DB >> 17437473

Immunogenicity study of abbreviated rabies preexposure vaccination schedules.

Pakamatz Khawplod1, Henry Wilde, Maneerat Benjavongkulchai, Chakrapol Sriaroon, Pranee Chomchey.   

Abstract

OBJECTIVE: To evaluate abbreviated preexposure rabies vaccination schedules that would reduce cost and shorten time required for completion.
METHOD: A random prospective immunogenicity study, using a group of 96 volunteer preclinical veterinary students, primary school children, and hospital-based health care workers. They were divided into six groups and administered abbreviated schedules of preexposure tissue culture rabies vaccines. Neutralizing antibodies were determined on days 0 and 360, and following boosters on days 367 and 374.
RESULTS: All subjects, including one group that received only 0.1 mL intradermally at two sites on one day, had detectable neutralizing antibody titers 1 year later and responded with an accelerated antibody response when given booster injections.
CONCLUSION: It might be possible to develop a 1-week and even one clinic visit preexposure vaccine schedule that would provide at least 1 year of immune memory.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17437473     DOI: 10.1111/j.1708-8305.2007.00120.x

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


  5 in total

1.  Rabies in travelers.

Authors:  Philippe Gautret; Philippe Parola
Journal:  Curr Infect Dis Rep       Date:  2014-03       Impact factor: 3.725

2.  Immunogenicity of Simulated PCECV Postexposure Booster Doses 1, 3, and 5 Years after 2-Dose and 3-Dose Primary Rabies Vaccination in Schoolchildren.

Authors:  Thavatchai Kamoltham; Wiravan Thinyounyong; Pakamatz Khawplod; Phran Phraisuwan; Phana Phongchamnaphai; Gerlind Anders; Claudius Malerczyk
Journal:  Adv Prev Med       Date:  2011-07-07

Review 3.  Pre-exposure rabies prophylaxis: a systematic review.

Authors:  Jocelyn A Kessels; Sergio Recuenco; Ana Maria Navarro-Vela; Raffy Deray; Marco Vigilato; Hildegund Ertl; David Durrheim; Helen Rees; Louis H Nel; Bernadette Abela-Ridder; Deborah Briggs
Journal:  Bull World Health Organ       Date:  2016-11-25       Impact factor: 9.408

4.  Immunogenicity and feasibility of intradermal vaccination against rabies in Quebec.

Authors:  Y Bui; M Sow; E Cambron-Goulet; E Levac; F Milord
Journal:  Can Commun Dis Rep       Date:  2015-03-05

Review 5.  Fractional dose of intradermal compared to intramuscular and subcutaneous vaccination - A systematic review and meta-analysis.

Authors:  Jenny L Schnyder; Cornelis A De Pijper; Hannah M Garcia Garrido; Joost G Daams; Abraham Goorhuis; Cornelis Stijnis; Frieder Schaumburg; Martin P Grobusch
Journal:  Travel Med Infect Dis       Date:  2020-09-06       Impact factor: 6.211

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.